Eli Lilly 2011 Annual Report Download - page 107
Download and view the complete annual report
Please find page 107 of the 2011 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97 -
98 -
99 -
100 -
101 -
102 -
103 -
104 -
105 -
106 -
107 -
108 -
109 -
110 -
111 -
112 -
113 -
114 -
115 -
116 -
117 -
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
 |
 |
PROXY STATEMENT
Science and Technology Committee
The science and technology committee:
• reviews and makes recommendations regarding the company’s strategic research goals and objectives
• reviews new developments, technologies, and trends in pharmaceutical research and development
• oversees matters of scientific and medical integrity and risk management.
Membership and Meetings of the Board and Its Committees
In 2011, each director attended more than 82 percent of the total number of meetings of the board and the commit-
tees on which he or she serves. In addition, all board members are expected to attend the annual meeting of share-
holders, and all the directors attended in 2011. Current committee membership and the number of meetings of the
board and each committee in 2011 are shown in the table below.
Name Board Audit Compensation
Directors and
Corporate
Governance Finance
Public
Policy and
Compliance Science and
Technology
Mr. Alvarez Member Member Member Member
Dr. Baicker Member Member
Sir Winfried Bischoff Member Member Chair
Mr. Eskew Member Chair Member
Dr. Feldstein Member Member Member Chair
Mr. Fyrwald Member Member Member
Dr. Gilman Member Member Chair
Mr. Hoover Member Member Member
Ms. Horn Lead Director Chair Member
Dr. Lechleiter Chair
Ms. Marram 1Member Member Chair
Mr. Oberhelman Member Member Member
Dr. Prendergast Member Member Member
Ms. Seifert Member Member Member
Number of 2011 Meetings 10 11 7 6 7 8 7
1Ms. Marram will take over as lead director in April 2012.
17